FDA sends UCB a complete response letter on its BLA for psoriasis-treating bimekizumab, citing deficiencies from a recent preapproval inspection as th...
A just-released, scathing (XXX INSERT XXX)23-page Form FDA-483 cites 10 GMP deficiencies at Sun Pharmaceutical Industries Halol manufacturing facility...
FDA approves an Eli Lilly NDA for Mounjaro (tirzepatide), a once-weekly injection to improve blood sugar control in adults with Type 2 diabetes, as an...
FDA clears a BD (Becton, Dickinson) 510(k) for its new automated, high-throughput infectious disease molecular diagnostics platform, BD COR.
FDA approves a Medtronic PMA for the Onyx Frontier drug-eluting stent, indicated for treating patients with coronary artery disease.
CDER medical office Joseph Rajendran explains FDAs role in developing technology to produce medical isotopes without using highly enriched uranium.
FDA provides an overview of its new Enterprise Modernization Action Plan effort.
The Government Accountability Office says FDA should develop a policy on starting and ending enforcement discretion for unauthorized tests in future p...